Cyteir Therapeutics
cyteir.comLocations
Cambridge, MA, USA · Lexington, MA, USA · Cambridge, MA, USA
industry
Biotechnology · DeepTech · Health
Size
1 - 10 employees
Stage
Series C+
founded in
2012
Cyteir is a clinical-stage oncology company that is focused on the discovery and development of next-generation synthetically lethal therapies to treat cancer. The company is using its expertise in DNA damage response biology to advance a pipeline of novel drug candidates that selectively target key cancer vulnerabilities. Cyteir’s wholly owned lead compound, CYT-0851, is a potent and selective, oral investigational drug that was designed to inhibit RAD51-mediated homologous recombination and the repair of double-strand DNA breaks.
Something looks off?Open jobs at Cyteir Therapeutics
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.